ARCHIVES

Move Starts To Strip Anticancer Drug Regulation From FDA After New Charges It Is Delaying INDs

This article is from The Cancer Letter archive.

Vol. 02 No. 42 | October 15, 1976

Download PDF Visit The Full Archive

Related Articles

UT-Houston Wins NIH Center Grant For Alternative Cancer Medicine Studies

November 3, 1995

Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer

June 24, 2005

Blacks Half As Likely To Get Surgery For Esophageal Cancer

January 28, 2005

NCAB Gives Life To Three CBCCP Contractors Marked For Termination; Compromise “Reasonable” – DeVita

May 30, 1980

NCA Asks HHS To Exempt From DRG Peer Reviewed Institutions With At Least 25 Protocol Patients

August 12, 1983

NEJM Papers, Interview With NCI’s Doroshow, Provide Justification For Regulatory Action on ESAs.

June 15, 2007